LEMAITRE VASCULAR, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
LEMAITRE VASCULAR, INC. (LMAT) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $75.03 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-26
- LEMAITRE VASCULAR, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $75.03M, a 42.02% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $52.83M, a 41.42% increase from fiscal 2023.
- LEMAITRE VASCULAR, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $37.36M, a 42.18% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $26.27M, a 23.07% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | $75.03M 10-K · filed 2026-02-26 |
| 2024-12-31 | $52.83M 10-K · filed 2026-02-26 |
| 2023-12-31 | $37.36M 10-K · filed 2026-02-26 |
| 2022-12-31 | $26.27M 10-K · filed 2025-02-28 |
| 2021-12-31 | $34.15M 10-K · filed 2024-02-29 |
| 2020-12-31 | $25.31M 10-K · filed 2023-03-01 |
| 2019-12-31 | $17.99M 10-K · filed 2022-02-28 |
| 2018-12-31 | $22.26M 10-K · filed 2021-03-12 |
| 2017-12-31 | $17.78M 10-K · filed 2020-03-12 |
| 2016-12-31 | $12.60M 10-K · filed 2019-03-11 |
| 2015-12-31 | $10.47M 10-K · filed 2018-03-09 |
| 2014-12-31 | $5.34M 10-K · filed 2017-03-09 |
| 2013-12-31 | $4.69M 10-K · filed 2016-03-10 |
| 2012-12-31 | $3.92M 10-K · filed 2015-03-18 |
| 2011-12-31 | $3.51M 10-K · filed 2014-03-21 |
| 2010-12-31 | $7.17M 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |